NCT07744152
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07744152
Title A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ESP | DEU | BEL

Facility Status City State Zip Country Details
UZ Leuven Leuven 3000 Belgium Details
Technische Universität Dresden Dresden 01307 Germany Details
Klinikum der Universität München AÖR München 81377 Germany Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Amsterdam (METC AVL) Amsterdam 1066CX Netherlands Details
Hospital del Mar Barcelona 08003 Spain Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Clínica Universidad de Navarra Navarra 31008 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field